Home › Funds › Patient Capital Management, LLC › GM

Patient Capital Management, LLC position in GM

GENERAL MTRS CO · Industrials

Patient Capital Management, LLC reported holding 612,724 shares of GM (GENERAL MTRS CO) in its Q3 2026 13F filing — a position valued at US$47.2M, representing 1.59% of its reported portfolio and ranking #23 among its reported holdings. Patient Capital Management, LLC has disclosed GM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)612.72K sh
Reported value held$47.18M
Portfolio Weight1.59%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Capital Management, LLC's GM position evolved

Patient Capital Management, LLC first disclosed a stake in GM in Q3 2023 at 1,621,305 shares (US$53.5M). The position peaked in Q4 2024 at 1,531,144 shares, worth US$81.6M. Across 13 filings, Patient Capital Management, LLC increased the stake 1 time(s), trimmed it 9 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 612,724 shares valued at US$47.2M — a reduction of -18,834 shares quarter over quarter.. Notable position changes include a 38% trim in Q2 2025 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.62M $53.45M New
Q4 2023 1.87M $67.04M Add
Q1 2024 1.80M $81.53M Reduce
Q2 2024 1.64M $76.15M Reduce
Q3 2024 1.55M $69.51M Reduce
Q4 2024 1.53M $81.56M Reduce
Q1 2025 1.53M $71.80M Hold
Q2 2025 944.75K $46.49M Reduce
Q3 2025 940.60K $57.35M Hold
Q4 2025 771.65K $62.75M Reduce
Q1 2026 744.63K $55.47M Reduce
Q2 2026 631.56K $48.68M Reduce
Q3 2026 612.72K $47.18M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GM and 13F data

GM (GENERAL MTRS CO) is a Industrials company. 29 other funds we track also report a position in GM — the largest reported positions include Franklin Resources (US$2.91B), D. E. Shaw & Co (US$1.16B), AQR Capital Management (US$1.08B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GM

All GM fund holders →

FAQ

How long has Patient Capital Management, LLC held GM?

Patient Capital Management, LLC has disclosed GM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Patient Capital Management, LLC's current position in GM?

As of Q3 2026, Patient Capital Management, LLC holds 612.72K shares of GM (GENERAL MTRS CO), valued at $47.18M, representing 1.59% of its reported portfolio and ranking #23.

Has Patient Capital Management, LLC been buying or selling GM?

In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in GM. The position peaked in Q4 2024 at 1.53M shares.

Which other funds hold GM?

Other major institutional holders of GM include Franklin Resources, D. E. Shaw & Co, AQR Capital Management, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.